Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.provenanceCONICET-
dc.creatorMedina, Vanina Araceli-
dc.creatorRivera, Elena S.-
dc.date2017-03-27T14:30:44Z-
dc.date2017-03-27T14:30:44Z-
dc.date2010-10-
dc.date2017-03-21T20:12:00Z-
dc.date.accessioned2019-04-29T15:33:25Z-
dc.date.available2019-04-29T15:33:25Z-
dc.date.issued2010-10-
dc.identifierMedina, Vanina Araceli; Rivera, Elena S.; Histamine receptors and cancer pharmacology; Wiley; British Journal of Pharmacology; 161; 4; 10-2010; 755-767-
dc.identifier0007-1188-
dc.identifierhttp://hdl.handle.net/11336/14251-
dc.identifier.urihttp://rodna.bn.gov.ar:8080/jspui/handle/bnmm/296484-
dc.descriptionConsiderable evidence has been collected indicating that histamine can modulate proliferation of different normal and malignant cells. High histamine biosynthesis and content together with histamine receptors have been reported in different human neoplasias including melanoma, colon and breast cancer, as well as in experimental tumours in which histamine has been postulated to behave as an important paracrine and autocrine regulator of proliferation. The discovery of the human histamine H(4) receptor in different tissues has contributed to our understanding of histamine role in numerous physiological and pathological conditions revealing novel functions for histamine and opening new perspectives in histamine pharmacology research. In the present review we aimed to briefly summarize current knowledge on histamine and histamine receptor involvement in cancer before focusing on some recent evidence supporting the novel role of histamine H(4) receptor in cancer progression representing a promising molecular target and avenue for cancer drug development.-
dc.descriptionFil: Medina, Vanina Araceli. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica; Argentina-
dc.descriptionFil: Rivera, Elena S.. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica; Argentina-
dc.formatapplication/pdf-
dc.formatapplication/pdf-
dc.languageeng-
dc.publisherWiley-
dc.relationinfo:eu-repo/semantics/altIdentifier/url/http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2010.00961.x/abstract-
dc.relationinfo:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1111/j.1476-5381.2010.00961.x-
dc.rightsinfo:eu-repo/semantics/restrictedAccess-
dc.rightshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/-
dc.sourcereponame:CONICET Digital (CONICET)-
dc.sourceinstname:Consejo Nacional de Investigaciones Científicas y Técnicas-
dc.sourceinstacron:CONICET-
dc.source.urihttp://hdl.handle.net/11336/14251-
dc.subjectHISTAMINE-
dc.subjectHISTAMINE H4 RECEPTOR-
dc.subjectCANCER PHARMACOLOGY-
dc.subjectBREAST CANCER-
dc.subjectMELANOMA-
dc.subjectCOLON CANCER-
dc.subjectHISTAMINE H4 RECEPTOR LIGANDS-
dc.subjectANTICANCER DRUGS-
dc.subjectCELL PROLIFERATION-
dc.subjectMALIGNANCY-
dc.subjectOncología-
dc.subjectMedicina Clínica-
dc.subjectCIENCIAS MÉDICAS Y DE LA SALUD-
dc.titleHistamine receptors and cancer pharmacology-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.typeinfo:ar-repo/semantics/articulo-
Aparece en las colecciones: CONICET

Ficheros en este ítem:
No hay ficheros asociados a este ítem.